Imuheptin caps (insect extract)

Pharmaceutical name: insect extract

COMPOSITION
Active substance: Imugeptin-150 mg;
Adjuvant: potato starch, microcrystalline cellulose, lactose monohydrate, magnesium stearat, talc, aerosil, nipagin, nipasol.

DESCRIPTION of the MEDICATION
Appearance of the capsule: capsules have the cylindrical form with the rounded ends, smooth matte surface.
The color of the capsule: the white body and dark blue lid, the white body and the white lid or the black body and the red lid.
Description of the capsule contents: amorphous hygroscopic powder and/or granules of brown or dark brown color, with the specific odour.

THE PHARMACEUTICAL FORM
Capsules
PHARMACOTHERAPEUTIC GROUP AND THE ATC-CODE
Immunomodulator L03AX
Hepatoprotector A05BA

PHARMACOLOGICAL PROPERTY
Imugeptin represents lipoprotein extracted from the tissues of the insects (eggs and larvae in the proportion 25 % to 75 %) of the Lepidoptere type, quite rich in its chemical composition. The wide spectrum of proteins, enzymes and appreciable and semi-appreciable amino acids promotes the reparative processes and the improvement of the specific functions of the organs, modeling of the immune system with increase of the organism resistance against the numerous internal and/or external influences. Pharmacological action of the medication is caused by the antioxidant effect of the components, by the stimulation of the albuminous synthesis, normalizing the phospholipid metabolism, stabilizing the hepatocyte membranes, strengthening the deintoxication functions of the liver, inhibition of the virus replication etc.

Imugeptin has the immunostimulating, antiproliferative, hepatoprotector, antioxidant and antiviral actions. The medication strengthens the deintoxication processes and increases the activity of the metabolic processes in the liver.

Components of the medication are donors of radicals who are used in the synthesis or represent the necessary substrata for the hepatocyte activity when combining with the toxic substances as a result of the metabolism. The large quantity of the water-soluble antioxidants assists the Imugeptin in inhibiting the lipid peroxydation that helps to reduce the affection of the hepatocyte membranes. This action benefits from the binding of the free radicals in the hepatic tissues. The phospholipids in the injured hepacytes lead to stabilization of the lysozyme membranes, and also prevent the loss of the intracellular components, for example, of the transaminase. In the immunodeficient state the medication normalizes the quantitative and quality indicators of the immune T-system, stimulates the production of the antibodies, lymphokines, improves the other parameters of the cellular immunity. Promotes the duplication and differentiation of the T-lymphocytes, normalizes the parity of the Т-and B- lymphocytes, strengthens the phagocytic activity of the neutrophils.

INDICATIONS
Imugeptin is recommended to adults as the hepatoprotector, adaptogenic, antioxidant medication, as the substitute for the amino acids in cases of the diseases of the liver, in the immunodeficient state, in the state of the endo- exotoxication, for the complex treatment of the infectious and inflammatory deseases, for the slow regenerative processes, in the immunodeficient state with prevailing disorder of the immunity, including for prevention of postoperative infectious complications, traumas and other pathological processes.

Mode of administration And DOZEs 2 capsules daily in 2-3 hours after the last meal for 3-6 months. The duration of the treatment depends on the clinical course of the disease.

OVERDOSE: no cases of the overdose registered.